Selectivity switch in transformation of CO2 from ethanol to methanol on Cu embedded in the defect carbon

The copper-based catalysts have been generally regarded as high-performance catalysts for CO_2 hydrogenation toward methanol,while the production of ethanol via C–C coupling on the copper-based catalysts is still challenging. Herein, we report a new catalyst where Cu nanoparticles are embedded in the carbon support with abundant defect sites, achieving a high selectivity for ethanol in the CO_2 hydrogenation. The experiments coupled with the theoretical studies show a clear map where carbon defects serve as anchor sites that can stabilize interfacial copper species, and interfacial Cu sites with low coordination numbers can adsorb two C_1 species and later convert them to a C_2 species via a hydrogenation-induced coupling reaction. Further adjacent Cu atoms of interfacial Cu sites can facilitate OH reduction reactions via the Cu–Cu bridge adsorption to assist the formation of ethanol. Especially, those specific active sites easily disappear in the reducing conditions and during the reaction, the major product can transform from ethanol to methanol.     

Design and In Vitro Evaluation of Solid-Lipid Nanoparticle Drug Delivery for Aceclofenac

Solid-lipid nanoparticles (SLNs) are an interesting nanoparticulate delivery system. The present work was carried out with the aim to develop a prolonged release solid-lipid nanoparticulate system for the drug using aceclofenac. Aceclofenac-loaded solid-lipid nanoparticles (ACSLNs) was prepared by hot high pressure homogenization technique. Tripalmitin was used as the lipid core. Surfactants (Poloxamer 188, Tween 80, and soya lecithin) and co-surfactant (sodium tauro glycholate) were used in the formulations. The prepared ACSLN formulations were characterized for encapsulation efficiency (EE), photon correlation spectroscopy (PCS), scanning electron microscopy (SEM), and x-ray diffraction (XRD). From these studies, mean particle diameter of the formulation prepared with combination of surfactants (Poloxmer 188 and Tween 80) was about 200 nm with spherical morphology and amorphous nature. Higher EE was obtained with SLNs prepared using combination of soya lecithin and poloxmer 188. The organization and distribution of the ingredients in the nanoparticulate system were studied by differential scanning calorimetry (DSC) and the results showed that the drug is incorporated into the solid matrix. The prepared formulations demonstrated favorable in vitro prolonged release characteristics. Experimental in vitro release data were substituted in available mathematical models to establish the release kinetics of ACSLNs and it was found to follow first-order kinetics and Higuchi diffusion mechanism. Our results suggest that these SLN formulations could constitute a promising approach for the drug delivery of aceclofenac.     

Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence

Background  

Opioid agonist drugs produce analgesia. However, long-term exposure to opioid agonists may lead to opioid dependence. The analgesic and addictive properties of opioid agonist drugs are mediated primarily via the mu-opioid receptor (MOR). Opioid agonists appear to alter neuronal morphology in key brain regions implicated in the development of opioid dependence. However, the precise role of the MOR in the development of these neuronal alterations remains elusive. We hypothesize that identifying and characterizing novel MOR interacting proteins (MORIPs) may help to elucidate the underlying mechanisms involved in the development of opioid dependence.     

Bimetallic Co–Ni/TiO<Subscript>2</Subscript> catalysts for selective hydrogenation of cinnamaldehyde

Bimetallic Co–Ni catalysts in the composition range Co_(1?x)Ni_x with x?=?0.0, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8 and 1.0, with total metal loading of 15% w/w and supported on TiO₂-P25, have been prepared by chemical reduction of the metal acetates by glucose in aqueous alkaline medium and characterized by XRD, TEM, TPR, XPS and H₂-TPD techniques. Selective hydrogenation of cinnamaldhyde (CAL) to hydrocinnamaldehyde (HCAL), cinnamyl alcohol (COL) and hydrocinnamyl alcohol (HCOL) has been investigated at 20 bar pressure, in the temperature range 120–140 °C. Co/Ni crystallite sizes in the range 6.0?±?1 nm are observed by TEM. TPR and XPS results indicate the formation of nanoscale Co–Ni alloys, which tend to weaken M–H bond strength, as revealed by H₂-TPD measurements. Ni/TiO₂ displays very high conversion of CAL (86.9%) with high selectivity (78.7%) towards HCAL formation at 140 °C. Co/TiO₂, on the other hand, exhibits relatively lower CAL conversion (55%) and higher selectivity (61.3%) for COL formation at the same temperature. However, bi-metallic Co–Ni catalysts in the composition range x?=?0.3–0.6 display very high conversion (>?98%) due to alloy formation and weakening of M–H bonds. Bimetallic Co_0.7Ni_0.3 catalyst displays high conversion of CAL (98.1%) and high selectivity (82.9%) towards HCOL. Overall CAL hydrogenation activity at 140 °C, when expressed as TOF, displays a maximum value at the composition Co_0.5Ni_0.5. Activity and selectivity patterns have been rationalized based on the reaction pathways observed on the catalysts and the influence of Co–Ni alloy formation and M–H bond strength. Thus, a synergetic effect, originating from an appropriate composition of base metal catalysts and reaction conditions, could result in hydrogenation activity comparable with noble metal based catalysts.     

Ultrasound irradiation in heterocycle synthesis: An overview

The synthesis of heterocyclic compounds has been a hot topic for several decades. Synthetic organic chemists are always in search of new methodologies which are greener for the synthesis of heterocyclic compounds. The ultrasound-assisted reactions have contributed much to this field. This review focuses on the impact of sonochemistry in the synthesis of heterocyclic compounds and covers the literature from 2009 to 2020.     

Rhodium(III)-catalyzed ring-opening of strained olefins through C–H activation of O-acetyl ketoximes: an efficient synthesis of trans-functionalized cyclopentenes and spiro[2.4]heptenes

An efficient strategy for the stereoselective synthesis of functionalized cyclopentenes and spiro[2.4]heptenes from strained olefins via C–H activation of aryl ketone O-acetyl ketoximes using [RhCl₂Cp^∗]₂ catalyst is described. The results revealed that a wide range of readily accessible aryl and heteroaryl ketoximes are compatible in this method for the ring opening of bicyclic and spirotricyclic olefins.     

Green synthesis and characterization of gold nanoparticles using extract of anti-tumor potent Crocus sativus

In the present study, we have explored anti-tumor potent Crocus sativus (saffron) as a reducing agent for one pot size controlled green synthesis of gold nanoparticles (AuNps) at ambient conditions. The nanoparticles were characterized using UV–vis, scanning electron microscope (SEM), high resolution transmission electron microscopy (HRTEM), X-ray diffraction (XRD) and FTIR analysis. The prepared AuNPs showed surface Plasmon resonance centered at 549 nm with average particle size of 15±5 nm. Stable, spherical and triangular crystalline AuNPs with well-defined dimensions were synthesized using anti-tumor potent Crocus sativus (saffron). Crystalline nature of the nanoparticles is confirmed from the HR-TEM, SAED and SEM images, and XRD patterns. From the FTIR spectra it is found that the biomolecules are responsible for capping in gold nanoparticles.     

Ag2Au50(PET)36 Nanocluster: Dimeric Assembly of Au25(PET)18 Enabled by Silver Atoms

The assembly of atomically precise metal nanoclusters offers exciting opportunities to gain fundamental insights into the hierarchical assembly of nanoparticles. However, it is still challenging to control the assembly of individual nanoclusters at a molecular or atomic level. Herein, we report the dimeric assembly of Au₂₅(PET)₁₈ (PET=2‐phenylethanethiol), where two Au₂₅(PET)₁₈ monomers are bridged together by two Ag atoms to form the Ag₂Au₅₀(PET)₃₆ dimer. The Ag₂Au₅₀(PET)₃₆ dimer is a unique mesomer, which has not been found in any other chiral metal nanoclusters. Furthermore, the Ag₂Au₅₀(PET)₃₆ dimer is distinct from the Au₂₅(PET)₁₈ monomer in its optical, electronic, and catalytic properties. This study is expected to provide a feasible strategy to precisely modulate the assembly of metal nanoclusters with controllable structures and properties.     

Synthesis,structural, DFT investigations and antibacterial activity assessment of pyrazoline-thiocyanatoethanone derivatives as thymidylate kinase inhibitors

Two novel compounds 1-(5-[4-fluorophenyl]-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-2-thiocyanatoethanone (FSCN) and 1-(5-[4-chlorophenyl]-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-2-thiocyanatoethanone (ClSCN) were synthesized and characterized by SC-XRD, 1H NMR, 13C NMR, FTIR, and UV methods. The X-ray diffraction studies were utilized to prove the 3D crystal structures of FSCN and ClSCN. In both the compounds, the packing is mostly driven by C H⋯N, C H⋯O, and C H⋯π (benzene ring as an acceptor) interactions. In ClSCN, additionally, the π⋯π interaction is observed between the pyrazole ring of one molecule and the benzene ring of the other molecule. The experimental values were compared with the results of DFT/B3LYP/6-311G++(d,p) theoretical computations. The pharmacological screening for FSCN and ClSCN was performed using molinspiration and PreADMET web server. To analyze antibacterial inhibition of the synthesized ligands and Ciprofloxacin (control drug) were interacted with antibacterial protein Thymidylate Kinase (TMK) (PDB ID: 4QGG) with the help of AutoDock Vina tool. The ADMET and docking results of FSCN and ClSCN pointed out the better drug likeness nature and good inhibition behavior with TMK protein. The antibacterial in vitro studies suggested that FSCN compound inhibited well with antibacterial strains than that of ClSCN. The current investigation suggests that with further improvements, our compounds could be preferred as substitute medicine for bacterial diseases.